Overcoming challenges in IBD management: Management of colonic dysplastic lesions

Digestive Diseases

Volumn 31, Issue 2, 2013, Pages 244-247

  Pellisé, Maria ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Chromoendoscopy; Colonic biopsies; Colorectal cancer; Inflammatory bowel disease

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; CANCER RISK; CANCER SCREENING; CHROMOENDOSCOPY; COLITIS; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; ENTERITIS; GASTROINTESTINAL DYSPLASIA; HUMAN; INTESTINE CANCER; PRACTICE GUIDELINE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; TUMOR INVASION; UNITED KINGDOM; ALGORITHM; COLON DISEASE; INFLAMMATORY BOWEL DISEASE; NARROW BAND IMAGING;

CARCINOGENESIS; COLONIC NEOPLASMS; HUMANS; INFLAMMATORY BOWEL DISEASES; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 84884216539     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000353381     Document Type: Article

References (20)

1. Kiesslich R, Fritsch J, Holtmann M, et al: Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-888.
2. Kiesslich R, Burg J, Vieth M, Gnaendiger J, Enders M, Delaney P, et al: Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 2004; 127: 706-713.
3. Hurlstone DP, Mcalindon ME, Sanders DS, Keogh R, Lobo AJ, Cross SS: Further validation of high magnification chromoscopic colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2004; 126: 376-377.
4. Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS: Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005; 37: 1186-1192.
5. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC: Pancolonic indigocarmin dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-260.
6. Rutter M, Bernstein C, Matsumoto T, et al: Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy 2004; 36: 1109-1114.
7. Marion JF, Waye JD, Present DH, Israel Y, Bodian C, Harpaz N, et al: Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008; 103: 2342-2349.
8. Subramanian V, Mannath J, Ragunath K, et al: Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 304-312.
9. Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T 3rd, McLeod R, Burgart LJ, Allen J, Brill JV: AGA Institute Medical Position Panel on Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. Gastroenterology 2010; 138: 738-745.
10. Cairns S, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJW, Evans GD, et al: Developed on behalf of The British Society of Gastroenterology and the Coloproctology for Great Britain and Ireland. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59: 666-690.
11. Van Assche G, Dugnass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, et al: Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: special situations. J Crohn Colitis 2013; 7: 1-33.
12. Pellisé M, Díaz Tasende J, Balaguer F, Bustamante- Balén M, Herráiz M, Herreros de Tejada A, et al: Technical review of advanced diagnostic endoscopy in patients at high risk of colorectal cancer. Gastroenterol Hepatol 2012; 35: 278-292.
13. Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ: Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 2003; 362: 373-374.
14. Rutter M, Bernstein C, Matsumoto T, Kiesslich R, Neurath MF: Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy 2004; 36: 1109-1114.
15. Dekker E, van den Broek FJ, Reitsma JB, et al: Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007; 39: 216-221.
16. van den Broek FJ, Fockens P, van Eeden S, et al: Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011; 43: 108-115.
17. Ignjatovic A, East JE, Subramanian V, et al: Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012; 107: 885-890.
18. Pellisé M, López-Cerón M, Rodríguez de Miguel C, Jimeno M, Zabalza M, Ricart E, et al: Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long standing inflammatory bowel disease: a prospective randomized crossover study. Gastrointest Endosc 2011; 74: 840-848.
19. Olaru AV, Florin M, Selaru MD, et al: Dynamic changes in the expression of micro-RNA-31 during inflammatory bowel diseaseassociated neoplastic transformation. Inflamm Bowel Dis 2011; 17: 221-231.
20. Kanaan Z, Rai SN, Eichenberger MR, Barnes C, Dworkin AM, Weller C, Cohen E, Roberts H, Keskey B, Petras RE, Crawford NPS, Galandiuk S: Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum Mutat 2012; 33: 551-560.